SOLICITATION NOTICE
68 -- Reagent (Chemistry) Kits
- Notice Date
- 7/28/2017
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 325414
— Biological Product (except Diagnostic) Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services - Rockville, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001, United States
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA_17-223-SOL-1180178(R)
- Archive Date
- 8/19/2017
- Point of Contact
- Howard Nesmith, Phone: 870-543-7459
- E-Mail Address
-
howard.nesmith@fda.hhs.gov
(howard.nesmith@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- THIS IS A SOURCES SOUGHT ANNOUNCEMENT, A MARKET SURVEY FOR WRITTEN INFORMATION ONLY. THIS IS NOT A SOLICITATION ANNOUNCEMENT FOR PROPOSALS AND NO CONTRACT WILL BE AWARDED FROM THIS ANNOUNCEMENT. NO REIMBURSEMENT WILL BE MADE FOR ANY COSTS ASSOCIATED WITH PROVIDING INFORMATION IN RESPONSE TO THIS ANNOUNCEMENT OR ANY FOLLOW-UP INFORMATION REQUESTS. NO TELEPHONE CALLS WILL BE ACCEPTED REQUESTING AN RFQ PACKAGE OR SOLICITATION. THERE IS NO RFQ PACKAGE OR SOLICITATION. IN ORDER TO PROTECT THE PROCUREMENT INTEGRITY OF ANY FUTURE PROCUREMENT, IF ANY, THAT MAY ARISE FROM THIS ANNOUNCEMENT, INFORMATION REGARDING THE TECHNICAL POINT OF CONTACT WILL NOT BE GIVEN AND NO APPOINTMENTS FOR PRESENTATIONS WILL BE MADE. The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS) has issued this sources sought announcement in an attempt to locate potential providers for all-inclusive Reagent (Chemistry) Kits to be used on a variety of Illumina Inc., MiniSeq, MiSeq, NextSeq, HiSeq, and NovaSeq series instruments. If your firm is considered a small business source under North American Industry Classification System (NAICS) 325414 - Biological Product (except Diagnostic) Manufacturing; with a Small Business Size Standard of 1,200 employees, and believe that your firm would be able to provide the FDA with the required Reagent Kits as described below, please submit an email to howard.nesmith@fda.hhs.gov. The vendor shall include information about the company which demonstrates they can meet all of the minimum requirements. Background/Statement of Need: Various Divisions of the Food and Drug Administration (FDA) to include: •CBER - Center for Biologics Evaluation and Research •CDER - Center for Drugs Evaluation and Research (DPA) (DMA) •CDRH - Center for Devices and Radiological Health •CFSAN - Center for Food Safety and Applied Nutrition •CTP - Center for Tobacco Products •CVM - Center for Veterinary Medicine •NCTR - National Center for Toxicological Research •ORA - Office of Regulatory Affairs are engaging in research, studies, and projects such as: •Genomics oWhole-Genome Sequencing oExome Sequencing oDe Novo Sequencing oTargeted Sequencing •Transcriptomics oTotal RNA and mRNA Sequencing oTargeted RNA Sequencing oSmall RNA and Noncoding RNA Sequencing •Epigenomics oMethylation Sequencing oChiP Sequencing oRibosome Profiling using a variety of Illumina Inc., MiniSeq, MiSeq, NextSeq, HiSeq, and NovaSeq series instruments. All of which require Reagent (Chemistry) Kits for data analysis as follows: •Sequencing by Synthesis (SBS) Kits •Cluster Density and Throughput Kits •DNA Library Preparation Kits •Sample Indexes Preparation Kit •RNA- Sequencing Kits Minimum Technical Requirements •All Reagent Kits offered shall be proven with documentation they are compatible for use with Illumina Inc., MiniSeq, MiSeq, NextSeq, HiSeq, and NovaSeq series instruments and their use will not void instrument warranty, maintenance and/or service agreements •Reagent Kits shall offer a wide range of solutions for applications •Provide efficient sequencing with high data quality •Optimal signal-to-noise ratio •High accuracy and paired-end sequencing capability •Multiple options for both sequencing output and read length •Ready-to-use / Ease-of-use Reagents FOB Destination: U.S. Food and Drug Administration at various locations throughout the United States Responses to this sources sought shall unequivocally demonstrate that the respondent is regularly engaged in the sale of same or substantially reagent kits. Though the target audience is small business or small businesses capable of providing service from another small business, all interested parties may respond. At a minimum, responses shall include the following: - Business name and bio, DUNS number, business address, business website, business size status (i.e., SB, VOSB, SDVOSB, HUBZone SB, SDB, WOSB, LB), point of contact name, mailing address (if different from business address), phone number and email address. Provide this same information again if responding to provide a service offered by another firm. - Past Performance information for the manufacturer and/or sale of same or substantially similar reagent kits shall include date of sale, description, dollar value, client name, client address, client contact name, client point of contact mailing address (if different from that provided for client), client point of contact phone number, client point of contact email address, and name of the manufacturer (to include DUNS number and size status) if not the respondent. - Descriptive literature, brochures, marketing material, etc. detailing the nature of the reagent kits the responding firm is regularly engaged in manufacturing and/or selling. - If applicable, identification of the firm's GSA Schedule contract(s) by Schedule number and SINs that are applicable to this potential requirement are also requested. If a large business, provide if subcontracting opportunities exist for small business concerns. The Government is not responsible for locating or securing any information, not identified in the response. Interested Contractors must respond with capability statements in person, by e-mail, fax, mail or other delivery method before 1:00 pm (Central Standard Time - Local Prevailing Time in Jefferson, Arkansas) on August 4, 2017 to howard.nesmith@fda.hhs.gov, Fax (870) 543-7990, or mail to the U. S. Food and Drug Administration, OO/OFBA/OAGS/DAP, Attention of Howard Nesmith, 3900 NCTR Road, Building 50, Room 424, Jefferson, AR 72079-9502 and Reference: FDA_17-223-SOL-1180178(R). Disclaimer and Important Notes This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre‐solicitation synopsis and solicitation may be published in FedBizOpps. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non‐proprietary technical information in any resultant solicitation(s). Additional Notes: If the stated requirements appear restrictive, please submit comments detailing the concern. Though this is not a request for quote, informational pricing for the service would be helpful.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA_17-223-SOL-1180178(R)/listing.html)
- Place of Performance
- Address: U.S. Food and Drug Administration at various locations throughout the United States, United States
- Record
- SN04603226-W 20170730/170728232313-7ddff1d86e865e5118562980d65b0582 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |